Ventas, Inc. (NYSE: VTR) announced that it has completed its previously announced acquisition of substantially all of the life science ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE